Why vascular & autonomic screening matter for modern practice

Background: Autonomic Nervous System & Vascular Health

The autonomic nervous system (ANS) regulates involuntary body functions: heart rate, blood pressure, sweat gland activity and vascular tone. Dysfunction in the ANS—including cardiac autonomic neuropathy—often precedes overt symptoms and may signal broader cardiovascular risk.

Standardized assessments such as Ewing tests have historically been used to evaluate these conditions. But modern automated systems now offer faster, more reproducible screening. Meanwhile, vascular screening—especially for PAD—remains under-utilized in many practices despite its association with morbidity.

The TM-Flow System focuses on both autonomic and vascular markers. The goal is to catch problems before major events occur. For example, small-fiber neuropathy shows up through sweating changes (sudomotor dysfunction). PAD can be found through an ankle-brachial index (ABI) test.

By offering both, the TM-Flow System aligns with preventive medicine goals.

What is the TM-Flow System?

At its core, the TM-Flow System is a diagnostic hardware+software platform that integrates three major assessments:

Ankle-Brachial Index (ABI) measurement for PAD screening.
Sudomotor function testing (via galvanic skin response or sweat gland assessment) to assess small-fiber nerve function or autonomic dysfunction.
Heart Rate Variability (HRV) and photoplethysmography (PPG) analysis to gauge autonomic balance and vascular endothelial/flow properties.
These combined measurements allow a physician to gather a broad assessment of autonomic and vascular health in a relatively short session—often 7–12 minutes.
The device is described as “FDA-cleared” for these uses.
In practical terms, the system includes the hardware (sensors/cuffs/electrodes), software interface and reporting module. It is designed for non-invasive use with minimal patient discomfort.

How the TM-Flow System Works in Practice

A typical TM-Flow test session works like this: First, the patient gets blood pressure cuffs on both arms and ankles for the ABI test. Next, electrodes or skin sensors are placed for the sudomotor check. Finally, a pulse/PPG sensor is attached for HRV and PPG readings.

the TM-Flow System automates much of the workflow, collecting the multi-modal data in under 10 minutes. Some providers report turnaround of 15 minutes.

The patient remains comfortable, seated or supine, sensors are applied quickly. And then the TM-Flow System executes the sequences. Once complete, a clear report is generated with key markers, interpretation aid, risk stratification and suggested next steps.

Fits Busy Practices

The workflow is designed to fit into busy practices. The patient experience is relatively low burden compared to many other vascular or autonomic tests.

Clinical Benefits for the Physician and Patient

Early detection: The device allows the physician to identify early vascular and autonomic abnormalities—in patients with risk factors. For example, assessing small-fiber nerve function (via sudomotor testing) or autonomic function (via HRV) may provide actionable data in diabetic or hypertensive patients. It also supports PAD screening via ABI in at-risk populations.
Improved diagnostic accuracy: By combining vascular and autonomic assessments, physicians gain a more holistic view of patient cardiovascular/neurovascular health. This can reduce the risk of mis-diagnosis or delayed intervention.
Patient engagement: Offering a “7-minute screening” of autonomic/vascular health can enhance patient engagement in preventative care. Patients often appreciate technology-enabled screening and the immediacy of results.
Better outcomes: Early identification permits earlier intervention (lifestyle, medications, referrals) and may slow progression of neuropathy, PAD or autonomic complications.

Practice & Financial Advantages

From a practice perspective, the diagnostic platform offers several attractive benefits:

Reimbursable CPT codes: For example, CPT 95921 (Autonomic Function Testing), 95923 (Sudomotor Testing) and 93922 (Ankle-Brachial Index) are cited as applicable to this device.
Clinical potential: Some practices report competitive reimbursement per test session combining the three codes.
Time efficiency: The test can be completed in under 10 minutes, meaning less chair time and higher throughput.
Practice differentiation: Having advanced screening in-office can set the clinic apart and make it a referral hub for vascular/neurovascular risk.
Thus, from a business & clinical operations viewpoint, the testing system can contribute both to patient care and practice growth.

Integration Into Your Clinic

Implementing the TM-Flow System requires attention to workflow, staffing, reporting integration, and how results inform each patient’s treatment plan. Key steps:

Staff training: While the user interface is designed to be user-friendly, practice staff need to be trained in sensor placement, patient prep and report interpretation. Many vendors provide onboarding and in-person or remote training.
Space & scheduling: Allocate a room or exam space for the 10-minute test, include in the wellness or risk-screening visit.
EHR/reporting: Ensure the TM-Flow software integrates or produces reports that can be uploaded or attached to your EMR. Some vendors highlight HL7/XML export.
Patient selection: Identify which patients in your panel would benefit (e.g., diabetics, smokers, hypertensives, those with neuropathic symptoms).
Consumables & maintenance: Consider disposables (electrodes), calibration, technical support.
With a thoughtful plan the TM-Flow System can be smoothly integrated into existing practice workflows.

Considerations Before Adoption

Before acquiring the TM-Flow System, physicians should evaluate:

Up-front cost vs expected clinical value: While reimbursements may be attractive, practice volume and patient mix matter. Some manufacturers provide financial projections (e.g., 10 tests/week scenario).
Staff time and training: Even though the test is quick, proper staff training and workflow adjustment are important.
Patient population: If your practice does not see many at-risk patients (e.g., diabetics, PAD risk), the yield may be lower.
Clinical interpretation: While the system delivers results, physician judgement remains essential. The technology should support—not replace—clinical decision-making.
Consumable and maintenance costs: Ensure you understand the recurring costs.
By weighing these factors, clinics can make an informed decision about the fit of TM-Flow in their setting.

Case Example / Real-World Use

For instance, an independent primary-care clinic implemented the TM-Flow System as part of its evaluation protocol for at-risk patients. They offered testing to patients over 50 with one or more risk factors (diabetes, hypertension, smoking).

The 7-minute test fit into the office flow; results were discussed immediately.

Patients with abnormal vascular or autonomic markers were referred earlier to specialist care or had lifestyle/medical interventions initiated. The practice reported increased patient satisfaction, perceived value and additional clinical value from billable codes.

What It Illustrates

Vendors cite such stories to illustrate practice transformation.

While each practice will differ, this type of example shows the potential of combining clinical benefit and business value.

Future Outlook & Practice Opportunities

As medicine shifts more toward value-based care, early detection of vascular and autonomic dysfunction will likely become even more important. Screening tools like the TM-Flow System position the clinic to offer proactive care, not just reactive.

Also, as patient awareness of “nerve health”, “microvascular health” and “autonomic balance” grows, offering a modern screening service may attract new patients.

also, integrating such diagnostics with lifestyle medicine, cardiology, endocrinology or neurology could expand your service offering. In short—the TM-Flow System could help your clinic move from “treating disease” to “managing risk and optimizing health”.

FAQs about the TM-Flow System

What patients are suitable for TM-Flow screening?
Patients with risk factors such as diabetes, hypertension, smoking, obesity or neuropathic symptoms (numbness, tingling) are good candidates.
How long does the test take and is it comfortable for patients?
The complete test typically takes 7–12 minutes and is non-invasive, involving sensor placement without needles.
Which CPT codes apply for reimbursement?
Commonly used: 93922 (ABI), 95921 (Autonomic Function Testing), 95923 (Sudomotor Testing).
What does the TM-Flow System measure exactly?
It measures ankle-brachial index for PAD, sudomotor (sweat gland) function for small-fiber neuropathy, and HRV/PPG for autonomic and vascular flow assessment.
How quickly can the system be integrated into a practice?
With proper planning, training and workflow adjustment, integration can happen within weeks rather than months. Vendor partners often provide onboarding support.
Are there limitations or contraindications?
While non-invasive, the system may not replace all vascular or neurology workups. Interpretation by a trained physician is essential. Also, practices must assess patient volume to justify cost.
Will this test duplicate other diagnostics I already do?
Possibly—but the value lies in combining vascular and autonomic screening in one session, which may capture dysfunction earlier than more traditional tests.
How does the TM-Flow System support practice capabilities?
By offering reimbursable diagnostic codes, short test duration, and offering a new service—there is potential to enhance practice capabilities while delivering value
What factors determine the cost of the TM-Flow system?
The investment varies from practice to practice. The main factors include whether you purchase the device outright or finance it, the configuration and level of training and onboarding you need, the ongoing support package you select, and whether an equipment trade-in or buyback applies. HealthWright Technologies provides a personalized quote based on your clinic’s specific situation rather than a one-size-fits-all price. Contact our team for a tailored cost assessment.
How much does the TM-Flow system cost?
There is no single list price, because the total cost of the TM-Flow system depends on your purchasing approach, configuration, training, and support needs (see the factors above). Rather than quote a figure that may not reflect your situation, HealthWright prepares a customized quote for each practice. Reach out for a no-obligation cost breakdown.

Conclusion

For physicians and medical practitioners keen on elevating their diagnostic toolkit through HealthWright Technologies, improving patient outcomes and supporting practice growth, the TM-Flow System represents a compelling opportunity.

With its non-invasive, rapid, multi-modal screening capabilities, it aligns with the preventive care shift and offers a practical integration path for busy practices. If you’re looking to advance both clinical care and operational efficiency, now may be the right time to explore how the TM-Flow System can fit into your workflow.

Continue Reading

How the TM-Flow System Enhances Chronic Disease Management Programs — Learn how the system integrates into chronic care workflows for conditions like diabetes, hypertension, and heart failure.
The Business Case for Adding CMAT™ TM-Flow Testing to Independent Clinics — Explore the financial and clinical value of integrating this diagnostic testing into your practice.
From PAD Screening to ANS Analysis: CMAT Triple-CPT Clinical Stack — Discover how the CMAT device delivers comprehensive cardiovascular and autonomic diagnostics.
Contact HealthWright Technologies to learn more about adding the TM-Flow System to your practice.

Bottom Line

This article covered the key aspects of introduction to the tm-flow system. For questions about implementation or to request a demo, contact HealthWright Technologies at contact@healthwrighttechnologies.com.

Ready to get started? Learn how HealthWright Advantage bundles the device, training, and ongoing support your practice needs — backed by a 90-day buyback guarantee.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis, treatment, and clinical decision-making.

CPT codes are provided for informational purposes only and do not guarantee reimbursement. Verify code applicability and coverage with the relevant payer and your billing department before submitting claims. CPT® is a registered trademark of the American Medical Association.

Related Clinical Guides

Ready to see the CMAT Advantage in your practice?

Book a free 15-minute demo — see the full PAD + autonomic workup and triple-CPT billing potential, with no obligation. Backed by our 90-day buyback guarantee.

Book a Free Demo →

Introduction to the TM-Flow System

In This Article

Background: Autonomic Nervous System & Vascular Health

What is the TM-Flow System?